19th International Congress of Immunology - IUIS 2025

Recent data suggest that vitamin K2 (VK2) supplementation has beneficial effects on inflammatory diseases, including rheumatoid arthritis (RA). However, the underlying mechanisms are poorly understood. In this study, the effects of VK2 and its potential anti-inflammatory/immunomodulatory properties were investigated in a rat model of RA, collagen-induced arthritis (CIA). Female Dark Agouti rats were immunized with bovine type II collagen (CII) in incomplete Freund`s adjuvant to induce CIA. Treatment with VK2 (MK-7) (50 mg/kg/day/orally) began one day prior to immunization and continued until the day of sacrifice. The clinical picture was determined by clinical scoring and histological analysis. The phenotypic and functional characteristics of lymphoid organ (LO) cells, including splenocytes and draining lymph node (dLN) cells, were analyzed by flow cytometry. Cytokine concentrations in hind paw tissue culture supernatants and levels of CII-specific IgG antibodies in serum were measured by ELISA. VK2 reduced the arthritic score and the severity of ankle joint inflammation in CIA rats. This was accompanied by a shift in the balance between proinflammatory (TNF-a and IL-6) and anti-inflammatory (IL-10) cytokines towards later in the paws of treated rats. CD11b+ cells in LOs of treated rats exhibited decreased production of TNF-a and IL-1b and decreased expression of CD86 (in dLNs and spleen) and MHC II and TLR4 (in spleen), suggesting a less inflammatory phenotype. Additionally, the frequencies of CD4+ cells producing IL-17 and IFN-g were lower in the dLNs, while regulatory CD4+FoxP3+ cell frequency was higher in the treated rats. Lower serum levels of CII-specific antibodies corresponded with a lower frequency of CD45RA+ cells (B cells) in the LOs of treated rats. These results suggest that preventive VK2 treatment improves the clinical presentation of RA in rat CIA model. Furthermore, they highlight potential mechanisms underlying its anti-inflammatory/immunoregulatory effect.

Publication Details

Published
2026-01-05
DOI
https://doi.org/10.3389/978-2-8325-6558-2
Primary Topic
Immune responses and vaccinations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

19th International Congress of Immunology - IUIS 2025

Immune responses and vaccinations
article

19th International Congress of Immunology - IUIS 2025

article en

Abstract

Recent data suggest that vitamin K2 (VK2) supplementation has beneficial effects on inflammatory diseases, including rheumatoid arthritis (RA). However, the underlying mechanisms are poorly understood. In this study, the effects of VK2 and its potential anti-inflammatory/immunomodulatory properties were investigated in a rat model of RA, collagen-induced arthritis (CIA). Female Dark Agouti rats were immunized with bovine type II collagen (CII) in incomplete Freund`s adjuvant to induce CIA. Treatment with VK2 (MK-7) (50 mg/kg/day/orally) began one day prior to immunization and continued until the day of sacrifice. The clinical picture was determined by clinical scoring and histological analysis. The phenotypic and functional characteristics of lymphoid organ (LO) cells, including splenocytes and draining lymph node (dLN) cells, were analyzed by flow cytometry. Cytokine concentrations in hind paw tissue culture supernatants and levels of CII-specific IgG antibodies in serum were measured by ELISA. VK2 reduced the arthritic score and the severity of ankle joint inflammation in CIA rats. This was accompanied by a shift in the balance between proinflammatory (TNF-a and IL-6) and anti-inflammatory (IL-10) cytokines towards later in the paws of treated rats. CD11b+ cells in LOs of treated rats exhibited decreased production of TNF-a and IL-1b and decreased expression of CD86 (in dLNs and spleen) and MHC II and TLR4 (in spleen), suggesting a less inflammatory phenotype. Additionally, the frequencies of CD4+ cells producing IL-17 and IFN-g were lower in the dLNs, while regulatory CD4+FoxP3+ cell frequency was higher in the treated rats. Lower serum levels of CII-specific antibodies corresponded with a lower frequency of CD45RA+ cells (B cells) in the LOs of treated rats. These results suggest that preventive VK2 treatment improves the clinical presentation of RA in rat CIA model. Furthermore, they highlight potential mechanisms underlying its anti-inflammatory/immunoregulatory effect.

Good health and well-being
Openalex Percentile: Top 97%
Immune responses and vaccinations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

19th International Congress of Immunology - IUIS 2025 · (2026) | TGRS Research Map | TGRS